COPPER Publications, 2011-Present – Sorted by Cancer Type

Sort by Topic

Names of COPPER members appear in bold


Fox JP, Zikmund-Fisher BJ, Gross CP. Older patient experiences in the mammography decision-making process. Arch Int Med. 2012;172(1):62-4. PMID22232149.

Soulos PRYu JBRoberts KBRaldow ACHerrin JLong JBGross CP. Assessing the impact of a cooperative group trial on breast cancer care in the Medicare population. J Clin Oncol. 2012;30(14):1601-7. PMID22393088.

Presley CJ, Soulos PR, Herrin J, Roberts KB, Yu JB, Killelea B, Lesnikoski B, Long JB, Gross CP. Patterns of use and short-term complications of breast brachytherapy in the national Medicare population in 2008-2009. J Clin Oncol. 2012;30(35):4302-7. PMID23091103.

Chen JLong JB, Hurria A, Owusu C, Steingart RM, Gross CP. Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer. J Am Coll Cardiol. 2012;60(24):2504-12. PMID23158536.

Feinstein AJ, Soulos PRLong JBHerrin JRoberts KBYu JBGross CP. Variation in Receipt of Radiation Therapy after Breast-Conserving Surgery: Assessing the Impact of Physicians and Geographic Regions. Med Care. 2013;51(4):330-338. PMID23151590.

Roberts KBSoulos PRHerrin JYu  JBLong JB, Dostaler E, Gross CP.  The Adoption of New Adjuvant Radiotherapy Modalities among Medicare Beneficiaries with Breast Cancer:  Clinical Correlates and Cost Implications. Int J Radiat Oncol Biol Phys. 2013;85(5):1186-92. PMID23182396.

Gross CPLong JBRoss JS, Abu-Khalaf M, Wang RKillelea BK, Gold HT, Chagpar ABMa X. The Cost of Breast Cancer Screening in the Medicare Population. JAMA Intern Med. 2013;173(3):220-6. PMID23303200.

Killelea BK, Long JB, Chagpar AB, Ma X, Soulos PR, Ross JS, Gross CP. Trends and Clinical Implications of Preoperative Breast MRI in Medicare Beneficiaries with Breast Cancer. Breast Cancer Res Treat. 2013;141(1):155-63. PMID23942872.  

Fox JP, Philip EJ, Gross CP, Desai RA, Killelea B, Desai MM. Associations between mental health and surgical outcomes among women undergoing mastectomy for cancer. Breast J. 2013;19(3):276-84. PMID23521554.

Ezaz G, Long JB, Gross CP, Chen J. Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer. J Am Heart Assoc. 2014;3(1):e000472. PMID24584736.

Killelea BK,Gross CP. Is the use of preoperative breast MRI resulting in more invasive breast cancer surgery? Women's Health (Lond Engl). 2014;10(1)1-3. PMID24328592.

Elmore JG, Gross CP. The Cost of Breast Cancer Screening in the United States: A Picture Is Worth... a Billion Dollars? Ann Intern Med. 2014;160(3):203-204-204. 

Sen S, Wang SY, Soulos PR, Frick KD, Long JB, Roberts KB, Yu JB, Evans SB, Chagpar AB, Gross CP. Examining the Cost-Effectiveness of Radiation Therapy Among Older Women With Favorable-Risk Breast Cancer. J Natl Cancer Inst. 2014;106(3):dju008. PMID24598714.

Sen S, Soulos PR, Herrin J, Roberts KB, Yu JB, Lesnikoski B, Ross JS, Krumholz HM, Gross CP. For-Profit Hospital Ownership Status and Use of Brachytherapy after Breast-Conserving Surgery. Surgery. 2014;155(5):776-88. PMID24787104.

Wang SY, Long JB, Hurria A, Owusu C, Steingart MR, Gross CP, Chen J. Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival. Breast Cancer Res Tr. 2014;146(2):411-9. PMID24951268.

Killelea BK, Long JB, Chagpar AB, Ma X, Wang R, Ross JS, Gross CP. Evolution of breast cancer screening in the Medicare population: Clinical and economic implications.  J Natl Cancer Inst. 2014;106(8). PMID25031307.

Wang EH, Mougalian SS, Soulos PR, Rutter CE, Evans SB, Haffty BG, Gross CP, Yu JB. Adoption of Hypofractionated-Whole Breast Irradiation for Early-stage Breast Cancer: a National Cancer Data Base Analysis. Int J Radiat Oncol Biol Phys. 2014; 90(5):993-1000. PMID25149661

Wang EH, Mougalian SS, Soulos PR, Smith BD, Haffty BG, Gross CP, Yu JB. Adoption of Intensity Modulated Radiation Therapy For Early-Stage Breast Cancer From 2004 Through 2011. Int J Radiat Oncol Biol Phys. 2015;91(2):303-11. PMID25442334.

Feinstein AJ, Long JB, Soulos PR, Ma X, Herrin J, Frick KD, Chagpar AB, Krumholz HM, Yu JB, Ross JS, Gross CP. Older Women with Localized Breast Cancer: Costs and Survival Rates Increased across Two Time Periods. Health Aff. 2015;34(4):592-600. PMID25847641

Rutter CE, Lester-Coll NG, Mancini BR, Corso CD, Park HS, Yeboa DN, Gross CP, Evans SB. The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer. Cancer. 2015;121(14):2331-40. PMID25810128.

Pollack CE, Soulos PR, Gross CP. Physician’s Peer Exposure and the Adoption of a New Cancer Treatment Modality. Cancer. 2015;121(16):2799-807. PMID25903304

Mougalian SS, Soulos PR, Killelea BK, Lannin DR, Abu-Khalaf M, DiGiovanna M, Sanft T, Pusztai L, Gross CP, Chagpar AB. Use of Neoadjuvant Chemotherapy for Stage I-III Breast Cancer in the United States. Cancer. 2015;121(15)2544-52. PMID25902916.

Evans SB, Yu JB. Hypofractionated radiation therapy versus conventionally fractionated radiation therapy for early-stage breast cancer: how do we choose? Future Oncol. 2015;11(15):2105-7. PMID26235175

Killelea BK, Yang VQ, Wang SY, Hayse B, Mougalian S, Horowitz NR, Chagpar AB, Pusztai L, Lannin DR. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Database. J Clin Oncol. 2015;33(36):4267-76. PMID26598753

Xu X, Herrin J, Soulos PR, Saraf A, Roberts KB, Killelea BK, Wang SY, Long JB, Wang R, Ma X, Gross CP. The Role of Patient Factors, Cancer Characteristics, and Treatment Patterns in the Cost of Care for Medicare Beneficiaries with Breast Cancer. Health Serv Res. 2016;51(1):167-86. PMID26119176

Wang SY, Long JB, Killelea BK, Evans SB, Roberts KB, Silber A, Gross CP. Preoperative Breast Magnetic Resonance Imaging and Contralateral Breast Cancer Occurrence Among Older Women With Breast Cancer. J Clin Oncol. 2016;34(4):321-8. PMID26628465

Rutter CE, Yao X, Mancini BR, Aminawung JA, Chagpar AB, Saglam O, Hofstatter EW, Abu-Khalaf M, Gross CP, Evans SB. Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer. Clin Breast Cancer. 2016;16(1):59-62. PMID26483315

Su KW, Hall J, Soulos PR, Abu-Khalaf MM, Evans SB, Mougalian SS, Rutter CE, Davidoff AJ, Gross CP. Association of 21-Gene Recurrence Score Assay and Adjuvant Chemotherapy Use in the Medicare Population, 2008-2011. J Geriatr Oncol. 2016;7(1):15-23. PMID26704661.

Howard DH, Soulos PR, Chagpar AB, Mougalian S, Killelea B, Gross CP. Contrary To Conventional Wisdom, Physicians Abandoned A Breast Cancer Treatment After A Trial Concluded It Was Ineffective. Health Aff. 2016;35(7):1309-15. PMID27385249.

Wang SY, Long JB, Killelea BK, Evans SB, Roberts KB, Silber A, Gross CP. Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ. Breast Cancer Res Treat. 2016;158(1):139-48. PMID27287780

Lester-Coll NH, Rutter CE, Evans SB. Cost-effectiveness assessment of lumpectomy cavity boost in elderly women with early stage estrogen receptor positive breast cancer receiving adjuvant radiotherapy. Radiother Oncol. 2016;119(1):52-6. PMID26867968

Yeboa DN, Evans SB. Contemporary Breast Radiotherapy and Cardiac Toxicity. Semin Radiat Oncol. 2016;26(1):71-8. PMID26617212.

Yeboa DN, Xu X, Jones BA, Soulos P, Gross C, Yu JB. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009. Am J Clin Oncol. 2016;39(6):568-574. PMID24879475.

Wang EH, Park HS, Rutter CE, Gross C, Soulos PR, Yu JB, Evans SB. Association between Access to Accelerated Partial Breast Irradiation and Utilization of Adjuvant Radiation Therapy. Cancer. 2017;123(3):502-511. PMID27657353

Davis BA, Aminawung JA, Abu-Khalaf MM, Evans SB, Su K, Mehta R, Wang SY, Gross CP. Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study. J Natl Compr Canc Netw. 2017;15(3):346-354. PMID28275035.

Stratton J, Hu X, Soulos PR, Davidoff AJ, Pusztai L, Gross CP, and Mougalian SS. Bone density screening in postmenopausal women with early stage breast cancer on aromatase inhibitors. J Oncol Pract. 2017;13(5):e505-e515 . PMID28267392

Pollack CE, Soulos PR, Herrin J, Xu X, Christakis NA, Forman HP, Yu JB, Killelea BK, Wang SY, Gross CP. The Impact of Social Contagion on Physician Adoption of Advanced Imaging Tests in Breast Cancer. J Natl Cancer Inst. 2017;109(8). PMID28376191

Lannin DR, Wang S. Are Small Breast Cancers Good because They Are Small or Small because They Are Good? N Engl J Med. 2017;376(23):2286-91. PMID28591529.

Zeidan AM, Long JB, Wang R, Hu X, Yu JB, Huntington SF, Abel GA, Mougalian SS, Podoltsev NA, Gore SD, Gross CP, Ma X, Davidoff AJ. Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study. PLoS One. 2017;12(9):e0184747. PMID28902882

Rahimy E, Hong JC, Gross CP, Hu X, Soulos PR, Shafman T, Connor HJ, Ross R, Yu JB, Dosoretz A, Evans SB. Increased Number of Beam Angles Is Associated With Higher Cardiac Dose in Adjuvant Fixed Gantry Intensity Modulated Radiation Therapy of Left-Sided Breast Cancer. Int J Radiat Oncol Biol Phys. 2017; 99(5):1137-1145; PMID28864402

Tannenbaum S, Soulos PR, Herrin J, Mougalian S, Long JB, Wang R, Ma X, Gross CP, Xu X. Regional Medicare Expenditures and Survival Among Older Women With Localized Breast Cancer. Med Care. 2017; 55(12):1030-1038; PMID29068906

Kelly G, Wang SY, Lucas G, Fraenkel L, Gross CP. Facilitating Meaningful Engagement on Community Advisory Committees in Patient-Centered Outcome Research. Prog Community Health Partnersh. 2017;11(3):243-251. PMID29056616.

Layne TM, Aminawung JA, Soulos PR, Nunez-Smith M, Nunez MA, Jones BA, Wang KH, Gross CP. Quality Of Breast Cancer Care In The US Territories: Insights From Medicare. Health Aff. 2018;37(3):421-428. PMID29505365.

Avraham T, Gross CP, Killelea BK. Connections Between Hospital Financial Distress, Physician Incentive, and Patient Access to Breast Reconstruction. JAMA Surg. 2018;153(4):351-352. PMID29214317

Killelea BK, Long JB, Dang W, Mougalian SS, Evans SB, Gross CP, Wang SY. Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ. Ann Surg Oncol. 2018;25(6):1521-1529. PMID29516364

Hong JC, Rahimy E, Gross CP, Shafman T, Hu X,Yu JB, Ross R, Finkelstein SE, Dosoretz A, Park HS, Soulos PR, Evans SB. Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings. Pract Radiat Oncol. 2018;8(3):e79-e86. PMID28888675

Wang SY, Dang W, Richman I, Mougalian SS, Evans SB, Gross CP. Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal. J Clin Oncol. 2018;36(16):1619-1627. PMID29659329.


Makarov DVYu JB, Desai RA, Penson DF, Gross CP. The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care. 2011;49(4):333-9. PMID21368677.

Yu JBMakarov DVGross C. A new formula for prostate cancer lymph node risk. Int J Radiat Oncol Biol Phys. 2011;80(1):69-75. PMID20594769.

Makarov DV, Desai RA, Yu JB, Sharma R, Abraham N, Albertsen PC, Person DF, Gross CP. The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the Medicare population. J Urol. 2012;187(1):97-102. PMID22088337.

Raldow ACPresley CJYu JB, Sharma R, Cramer LDSoulos PRLong JBMakarov DVGross CP. The relationship between clinical benefit and receipt of curative therapy for prostate cancer. Arch Intern Med. 2012;172(4):362-3. PMID22371925.

Makarov DV, Desai RA, Yu JB, Sharma R, Abraham N, Albertsen PC, Krumholz HM, Penson DF, Gross CP. Appropriate and inappropriate imaging rates for prostate cancer go hand in hand by region, as if set by thermostat. Health Aff. 2012;31(4):730-40. PMID22492890.

Ross JS, Wang R, Long JB, Gross CP, Ma X. Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries. Arch Intern Med. 2012;172(2):1601-3. PMID22987029.

Quon JL, Yu JB, Soulos PR, Gross CP. The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancer. J Geriatric Oncol. 2013;4(1):9-18. PMID23482846.

Yu JBSoulos PRHerrin JCramer LD, Potosky AL, Roberts KBGross CP. Proton versus intensity-modulated radiotherapy for prostate cancer:  Patterns of care and early toxicity. J Natl Cancer Inst. 2013;105(1):25-32. PMID23243199.

Presley CJRaldow ACCramer LDSoulos PRLong JBYu JB , Makarov DVGross CP. A New Approach to Understanding Racial Disparities in Prostate Cancer Treatment. J Getriatric Oncol. 2013;4(1):1-8. PMID23828723.

Kim SP, Tilburt JC, Karnes RJ, Ziegenfuss JY, Han LC, Shah ND, Frank I, Smaldone MC, Gross CP, Yu JB, Trinh QD, Sun M, O'Malley RL, Nguyen PL. Variation in treatment recommendations of adjuvant radiation therapy for high-risk prostate cancer by physician specialty. Urology. 2013;82(4):807-12. PMID23910088

Yu JB. Prostate cancer: Interpreting cost-utility analysis of prostate cancer treatment. Nat Rev Urol. 2013;10(3):129-31. PMID23399726.

Ma X, Wang R, Long JB, Ross JS, Soulos PR, Yu JB, Makarov DV, Gold HT, Gross CP. The Cost Implications of Prostate Cancer Screening in the Medicare Population. Cancer. 2014;120(1):96-102. PMID24122801.

Kim SP, Karnes RJ, Nguyen PL, Ziegenfuss JY, Thompson RH, Han LC, Shah ND, Smaldone MC, Gross CP, Frank I, Weight CJ, Beebe TJ, Tilburt JC. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer. BJU Int. 2014;113(5b):E106-11. PMID24053213.

Aneja S Yu JB. Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy. Semin Radiat Oncol. 2014;24(1):35-42. PMID24314340.

Yu JB, Cramer LD, Herrin J, Soulos PR, Potosky AL, Gross CP. Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Comparison of Toxicity. J Clin Oncol. 2014;32(12)1195-201. PMID24616315.

Wang SY, Wang R, Yu JB, Ma X, Xu X, Kim SP, Soulos PR, Saraf A, Gross CP. Understanding regional variation in medicare expenditures for initial episodes of prostate cancer care. Med Care. 2014:52(8):680-7. PMID25023913.

Yu JB. The daily miracle of palliative radiotherapy for prostate cancer. Oncology. 2014;28(4):261. PMID24839796

Kim SP, Smaldone MC. The role of radical prostatectomy and lymph node dissection in the treatment of young men with high-grade node-positive prostate cancer: there may be no RCTs-but there are good reasons to include surgery. Oncology. 2014;28(6):522-524. PMID25134328.

Kim SP, Gross CP, Nguyen PL, Smaldone MC, Shah ND, Karnes RJ, Thompson RH, Han LC, Yu JB, Trinh QD, Ziegenfuss JY, Sun M, Tilburt JC. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care. 2014;52(7):579-85. PMID24926704

Han LC, Delpe S, Shah ND, Ziegenfuss JY, Tilburt JC, Karnes RJ, Nguyen PL, Gross CP, Yu JB, Trinh QD, Sun M, Ranasinghe WK, Kim SP. Perceptions of radiation oncologists and urologists on sources and type of evidence to inform prostate cancer treatment decisions. Int J Radiat Oncol Biol Phys. 2014; 89(2):277-83. PMID24685153

Kim SP, Gross CP, Nguyen PL, Smaldone MC, Thompson RH, Shah ND, Kutikov A, Han LC, Karnes RJ, Ziegenfuss JY, Tilburt JC. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer. Prostate Cancer Prostatic Dis. 2014; 17(2):163-9. PMID24566445.

Kim SP, Gross CP, Smaldone MC, Han LC, Van Houten H, Lotan Y, Svatek RS, Thompson RH, Karnes RJ, Trinh QD, Kutikov A, Shah ND. Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient population. Prostate Cancer Prostatic Dis. 2015;18(1):13-7. PMID25311766

Wang EH, Yu JB, Gross CP, Smaldone MC, Shah ND, Trinh QD, Nguyen PL, Sun M, Han LC, Kim SP. Variation in Pelvic Lymph Node Dissection among Patients Undergoing Radical Prostatectomy by Hospital Characteristics and Surgical Approach: Results from the National Cancer Database. J Urol. 2015;193(3):820-5. PMID25242393.

Yu JB, Sandler HM. Stereotactic body radiation therapy: Let's not give up on progress. Pract Radiat Oncol. 2015;5(3):193-6. PMID25413388

Makarov DV, Sen S, Soulos PR, Gold HT, Yu JB, Ross J, Gross CP. Regional-level inappropriate imaging rates for prostate and breast cancers are correlated: Potential Implications for Choosing Wisely. JAMA Oncol. 2015;1(2):185-194. PMID26181021.

Wang EH, Yu JB, Gross CP, Abouassaly R, Cherullo EE, Smaldone MC, Shah ND, Kiechle J, Trinh QD, Sun M, Kim SP. Association between surgeon and hospital characteristics and lymph node counts from radical prostatectomy and pelvic lymph node dissection. Urology. 2015;85(4)890-5. PMID25817114

Wang EH, Gross CP, Tilburt JC, Yu JB, Nguyen PL, Smaldone MC, Shah ND, Abouassally R, Sun M, Kim SP. Shared decision making and use of decision AIDS for localized prostate cancer: perceptions from radiation oncologists and urologists. JAMA Intern Med. 2015;175(5):792-9. PMID25751604.

Su KW, Hall J, Ross R, Soulos PR, Shafman TD, Yu JB, Dosoretz AP, Dosoretz DE, Finkelstein SE, Salenius S, Evans SB, Decker RH, Gross CP. Changes in Prostate Cancer Presentation for Radiation Oncology Care in Southwest Florida, 2007-2013. Contemporary Radiation Oncology. 2015;1(2):6-12. Link.

Lester-Coll NH, Park HS, Rutter CE, Corso CD, Mancini BR, Yeboa DN, Kim SP, Gross CP, Yu JB. The Association between Evaluation at Academic Centers and the Likelihood of Expectant Management in Low-Risk Prostate Cancer. Urology. 2016;96:128-135. PMID27392652

Lester-Coll NH, Johnson S, Magnuson WJ, Goldhaber SZ, Sher DJ, D'Amico AV, Yu JB. Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer. J Natl Cancer Inst. 2016;109(6). PMID28040795

Kim SP, Karnes RJ, Gross CP, Meropol NJ, Van Houten H, Abouassaly R, Shah ND. Contemporary National Trends of Prostate Cancer Screening Among Privately Insured Men in the United States. Urology. 2016;97:111-117. PMID27527411

Johnson SB, Soulos PR, Shafman TD, Mantz CA, Dosoretz AP, Ross R, Finkelstein SE, Collins SP, Suy S, Brower JV, Ritter MA, King CR, Kupelian PA, Horwitz EM, Pollack A, Abramowitz MC, Hallman MA, Faria S, Gross CP, and Yu JB. Patient-reported quality of life after stereotactic body radiation therapy vs. moderate hypofractionation for clinically localized prostate cancer. Radiother Oncol. 2016;121(2)294-298. PMID27890426.

Yu JB. Hypofractionated Radiotherapy for Prostate Cancer: Further Evidence to Tip the Scales. J Clin Oncol. 2017;35(17):1867-1869. PMID28355114

Yu JB, Hamstra D. Point: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy? Oncology. 2017;31(11):830-2. PMID29179251.

Mahal AR, Mahal BA, Nguyen PL, Yu JB. Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance. Cancer. 2018; 124(4):752-759; PMID29084350.


Park HSDetterbeck FC, Boffa DJ, Kim AW. Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg. 2012;93(2):372-9. PMID21945225.

Vest M, Tanoue TSoulos PRKim AWDetterbeck FMorgensztern D, Gross CP. Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer. J Thorac Oncol. 2012;7(1):188-95 PMID22134069.

Kim AW, Detterbeck FC, Boffa DJ, Decker RHSoulos PRCramer LDGross CP. Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer. Ann Thorac Surg. 2012;94(3):895-901. PMID22835558.

Vest MTHerrin JSoulos PRDecker RH, Tanoue L, Michaud G, Kim AW, Detterbeck F, Morgensztern D, Gross CP. Use of New Treatment Modalities for Non-Small Cell Lung Cancer Care in the Medicare Population. Chest. 2013;143(2):429-435. PMID23187634.

Moreno AC, Morgensztern D, Yu JB, Boffa DJ, Decker RH, Detterbeck FC, Kim AW. Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database. J Surg Res. 2013;184(1):10-8. PMID23583079.

Moreno AC, Morgensztern D, Boffa DJ, Decker RH, Yu JB, Detterbeck FC, Wang Z, Rose MG, Kim AW. Treating Locally Advanced Disease: An Analysis of Very Large, Hilar Lymph Node Positive Non-Small Cell Lung Cancer Using the National Cancer Data Base. Ann Thorac Surg. 2014;97(4):1149-55. PMID24582051

Park HS, Decker RH, Wilson LD, Yu JB. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases. Clin Lung Cancer. 2015;16(4):292-7. PMID25499149

Yu JB, Soulos PR, Cramer LD, Decker RH, Kim AW, Gross CP. The Comparative Effectiveness of Surgery and Radiosurgery for Stage I Non-Small Cell Lung Cancer. Cancer. 2015;121(14):2341-9. PMID25847699

Wang EH, Rutter CE, Corso CD, Decker RH, Wilson LD, Kim AW, Yu JB, Park HS. Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer. J Thorac Oncol. 2015;10(6):937-43. PMID25738221.

Corso CD, Park HS, Kim AW, Yu JB, Husain Z, Decker RH. Racial disparities in the use of SBRT for treating early-stage lung cancer. Lung Cancer. 2015;89(2):133-8. PMID26051446

Wang EH, Corso CD, Rutter CE, Park HS, Chen AB, Kim AW, Wilson LD, Decker RH, Yu JB. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer. J Clin Oncol. 2015;33(25):2727-34. PMID26101240.

Corso CD, Rutter CE, Park HS, Lester-Coll NH, Kim AW, Wilson LD, Husain ZA, Lilenbaum RC, Yu JB, Decker RH. Role of Chemoradiotherapy in Elderly Patients With Limited-Stage Small-Cell Lung Cancer. J Clin Oncol. 2015;33(36):4240-6. PMID26481366

Park HS, Decker RH, Wilson LD, Yu JB. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases. Clin Lung Cancer. 2015;16(4):292-7. PMID25499149.

Presley CJ, Gross CP, Lilenbaum RC. Optimizing Treatment Risk and Benefit for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Right Treatment for the Right Patient. J Clin Oncol. 2016;34(13):1438-42. PMID27001591

Erb CT, Su KW, Soulos PR, Tanoue LT, Gross CP. Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population. Lung Cancer. 2016;99:200-7. PMID27565940.

Liu J, Hancock JG, Moreno AC, Wang Z, Boffa DJ, Detterbeck FC, Kim AW. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase. EurJ Card iothorac Surg. 2016;49(2):596-601. PMID25890936

Rosen JE, Salazar MC, Wang Z, Yu JB, Decker RH, Kim AW, Detterbeck FC, Boffa DJ. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. J Thorac Cardiovasc Surg. 2016;152(1):44-54. PMID27131846

Jean RA, DeLuzio MR, Kraev AI, Wang G, Boffa DJ, Detterbeck FC, Wang Z, Kim AW. Analyzing Risk Factors for Morbidity and Mortality after Lung Resection for Lung Cancer Using the NSQIP Database. J Am Coll Surg. 2016;222(6):992-1000. PMID27118714

Arnold BN, Thomas DC, Rosen JE, Salazar MC, Blasberg JD, Boffa DJ, Detterbeck FC, Kim AW. Lung Cancer in the Very Young: Treatment and Survival in the National Cancer Data Base. J Thorac Oncol. 2016 Jul;11(7):1121-31. PMID27103511

DeLuzio MR, Keshava HB, Wang Z, Boffa DJ, Detterbeck FC, Kim AW. A model for predicting prolonged length of stay in patients undergoing anatomical lung resection: a National Surgical Quality Improvement Program (NSQIP) database study. Interact Cardiovasc Thorac Surg. 2016;23(2):208-15. PMID27073262

Rosen JE, Keshava HB, Yao X, Kim AW, Detterbeck FC, Boffa DJ. The Natural History of Operable Non-Small Cell Lung Cancer in the National Cancer Database. Ann Thorac Surg. 2016;101(5):1850-5. PMID27041452

Salazar MC, Rosen JE, Arnold BN, Thomas DC, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Adjuvant Chemotherapy for T3 Non-Small Cell Lung Cancer with Additional Tumor Nodules in the Same Lobe. J Thorac Oncol. 2016;11(7):1090-100. PMID27013407

Sandler BJ, Wang Z, Hancock JG, Boffa DJ, Detterbeck FC, Kim AW. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm. Ann Surg Oncol. 2016;23(2):638-45. PMID26474557

Lester-Coll NH, Rutter CE, Bledsoe TJ, Goldberg SB, Decker RH, Yu JB. Cost-Effectiveness of Surgery, Stereotactic Body Radiation Therapy, and Systemic Therapy for Pulmonary Oligometastases. Int J Radiat Oncol Biol Phys. 2016;95(2):663-72. PMID27055395.

Stahl JM, Ross R, Harder EM, Mancini BR, Soulos PR, Finkelstein SE, Shafman TD, Dosoretz AP, Evans SB, Husain ZA, Yu JB, Gross CP, Decker RH. The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016;96(5):1011-1020. PMID27869080

Harder EM, Park HS, Chen ZJ, Decker RH. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy. Pract Radiat Oncol. 2016;6:e353-e359. PMID27156424.

Jawitz OK, Wang Z, Boffa DJ, Detterbeck FC, Blasberg JD, Kim AW. The differential impact of preoperative comorbidity on perioperative outcomes following thoracoscopic and open lobectomies. Eur J Cardiothorac Surg. 2017;51(1):169-174. PMID27458143

Tchouta LN, Park HS, Boffa DJ, Blasberg JD, Detterbeck FC, Kim AW. Hospital volume and outcomes of robot-assisted lobectomies. Chest. 2017;151(2):329-339. PMID27687847

Gao SJ, Corso CD, Wang EH, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2017;12(2):314-322. PMID27720827

Thomas DC, Arnold BN, Rosen JE, Salazar MC, Blasberg JD, Detterbeck FC, Boffa DJ, Kim AW. Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery. Lung Cancer. 2017;103:75-81. PMID28024700

Gao SJ, Corso CD, Blasberg JD, Detterbeck FC, Boffa DJ, Decker RH, Kim AW. Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall. Clin Lung Cancer. 2017;18(2):169-177. PMID27890561.

Salazar MC, Rosen JE, Wang Z, Arnold BN, Thomas DC, Herbst RS, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery. JAMA Oncol. 2017;3(5):610-619. PMID28056112

Rosen JE, Salazar MC, Dharmarajan K, Kim AW, Detterbeck FC, Boffa DJ. Length of Stay From the Hospital Perspective: Practice of Early Discharge Is Not Associated With Increased Readmission Risk After Lung Cancer Surgery. Ann Surg. 2017;266(2):383-388. PMID27564681.

Presley CJ, Soulos PR, Tinetti M, Montori VM, Yu JB, Gross CP. Treatment burden among Medicare beneficiaries with early-stage lung cancer. J Oncol Pract. 2017;13(2):e98-e107. PMID27997301

Dhanasopon AP, Salazar MC, Hoag JR, Rosen JE, Kim AW, Detterbeck FC, Blasberg JD, Boffa DJ. Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging System. Ann Thorac Surg. 2017; 104(6):1829-1836; PMID29074151.

Wang EH, Corso CD, Park HS, Chen AB, Wilson LD, Kim AW, Decker RH, Yu JB. Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer. Am J Clin Oncol. 2018; 41(2):152–158; PMID26523443

Thomas DC, Arnold BN, Hoag JR, Salazar MC, Boffa DJ, Detterbeck FC, Kim AW, Blasberg JD. Timing and Risk Factors Associated with Venous Thromboembolism Following Lung Cancer Resection. Ann Thorac Surg. 2018;105(5):1469-1475. PMID29501644

Resio BJ, Chiu AS, Hoag J, Dhanasopon AP, Blasberg JD, Boffa DJ. Primary Salivary Type Lung Cancers in the National Cancer Database. Ann Thorac Surg. 2018;105(6):1633-1639. PMID29486180.


Gross CP, Soulos PR, Ross JS, Cramer LD, Guerrero C, Tinetti ME, Braithwaite RS. Assessing the impact of screening colonoscopy on mortality in the Medicare population. J Gen Intern Med. 2011;26(12):1441-9. PMID21842323

Fox J, Gross CP, Longo W, Reddy V. Laparoscopic colectomy for the treatment of cancer has been widely adopted in the United States. Dis Colon Rectum. 2012;55(5):501-8. PMID22513427.

Khiani VS, Soulos P, Gancayco J, Gross CP. Anesthesiologist involvement in screening colonoscopy: Temporal trends and cost implications in the Medicare population. Clin Gastroenterol Hepatol. 2012;10(1):58-64. PMID21782768.

Fox JP, Desai MM, Krumholz HM, Gross CP. Hospital-level outcomes associated with laparoscopic colectomy for cancer in the minimally invasive era. J Gastrointest Surg. 2012;16(11):2112-9. PMID22948842.

Gancayco J, Soulos PR, Khiani V, Cramer LD, Ross JS, Genao I, Tinetti M, Gross CP. Age and Sex-Based Disparities in Screening Colonoscopy Use Among Medicare Beneficiaries. J Clin Gastroenterol. 2013;47(7):630-6. PMID23619827.  

Yang DX, Gross CP, Soulos PR, Yu JB. Estimating the magnitude of colorectal cancers prevented during the era of screening. Cancer. 2014;120(18):2893-901. PMID24894740.

Fox JP, Burkardt DD, Ranasinghe I, Gross CP. Hospital-based acute care after outpatient colonoscopy: implications for quality measurement in the ambulatory setting. Med Care. 2014; 52(9):801-8. PMID24984212.


Wang R, Gross CP, Maggiore RJ, Halene SSoulos PR, Raza A, Galili N, Ma X. Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes. Leuk Res. 2011;35(7):904-8. PMID21067809.

Wang RGross CP, Frick K, Xu XLong J, Raza A, Galili N, Zikria J, Guan Y, Ma X. The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes. Leuk Res. 2012;36(11):1370-5. PMID22917770.

Nath SK, Yu JB, Wilson LD. Poorer Prognosis of African-American Patients With Mycosis Fungoides: An Analysis of the SEER Dataset, 1988 to 2008. Clin Lymphoma Myeloma Leuk. 2014;14(5):419-23. PMID24508350

Zeidan AM, Wang R, Davidoff AJ, Ma S, Zhao Y, Gore SD, Gross CP, Ma X. Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes. Cancer. 2016;122(10):1598-607. PMID26970288.

Zeidan AM, Davidoff AJ, Long JB, Hu X, Wang R, Ma X, Gross CP, Abel GA, Huntington SF, Podoltsev NA, Hajime U, Prebet T, Gore SD. Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes. Br J Haematol. 2016;175(5):829-840. PMID27650975.

Zeidan AM, Wang R, Gross CP, Gore SD, Huntington SF, Prebet T, Abel GA, Davidoff AJ, Ma X. Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United States. Leuk Lymphoma. 2017;58(4):982-985. PMID27558206

Wang R, Zeidan A, Soulos PR, Yu JB, Davidoff AJ, Gore SD, Gross CP, and Ma X. Myelodysplastic syndromes and acute myeloid leukemia in prostate cancer patients after radiotherapy: a population-based study. Prostate. 2017;77(5):437-445. PMID27868212.

Hui L, von Keudell G, Wang R, Zeidan AM, Gore SD, Ma X, Davidoff AJ, Huntington SF. Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation. Cancer. 2017;123(19):3763-3771. PMID28640385

Zeidan AM, Hu X, Long JB, Wang R, Ma X, Podoltsev N, Huntington SF, Gore SD, Davidoff AJ. Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic Leukemia in the United States: A large population-based study. Cancer. 2017;123(19):3754-3762. PMID28621841

Wang R, Zeidan AM, Halene S, Xu X, Davidoff AJ, Huntington SF, Podoltsev NA, Gross CP, Gore SD, Ma X. Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life. J Clin Oncol. 2017;35(30):3417-3424. PMID28783450.

Zeidan AM, Stahl M, Hu X, Wang R, Huntington SF, Podoltsev NA, Gore SD, Ma X, Davidoff AJ. Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantation. Blood. 2018;131(7):818-821. PMID29259002

Zeidan AM, Stahl M, DeVeaux M, Giri S, Huntington S, Podoltsev N, Wang R, Ma X, Davidoff AJ, Gore SD. Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates? Blood Cancer J. 2018;8(6):55. PMID29891916.


Viola KV, Jhaveri MB, Soulos PR, Turner RB, Tolpinrud WL, Doshi D, Gross CP. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population. Arch Dermatol. 2012;148(4):473-7. PMID22508870.

Lott JP, Gross CP. Mortality from nonneoplastic skin disease in the United States. J Am Acad Dermatol. 2014; 70(1):47-54. PMID24238577

Lott JP, Gross CP, Bosenberg M. County-level association of melanoma and papillary thyroid cancer: evidence of shared environmental risk? Pigment Cell Melanoma Res. 2015;28(1):120-3. PMID25308247.

Lott JP, Narayan D, Soulos PR, Aminawung J,Gross CP. Surgical Delay for Melanoma among Medicare Beneficiaries. JAMA Dermatol. 2015;151(7):731-41. PMID25853865.


Yu JBSoulos PR, Sharma R, Makarov DVDecker RH, Smith BD, Desai RA, Cramer LDGross CP. Patterns of care and outcomes associated with intensity modulated radiation therapy versus conventional radiation therapy for older patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2012;83(1):e101-7. PMID22342095

Aneja S, Khullar D, Yu JB. The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme. J Neurooncol. 2013;112(3):393-401. PMID23412775.

Yu JB. Breast cancer brain metastases: one step at a time. Oncology. 2014;28(7):570. PMID25144275

Lester-Coll NH, Dosoretz AP, Yu JB. Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases. Int J Radiat Oncol Biol Phys. 2014;89(3):563-8. PMID24751412.

Wang C, Roberts KB, Bindra RS, Chiang VL, Yu JB. Delayed cerebral vasculopathy following cranial radiation therapy for pediatric tumors. Pediatr Neurol. 2014; 50(6):549-56. PMID24739378

Park HS, Wang EH, Rutter CE, Corso CD, Chiang VL, Yu JB. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US. J Neurosurg. 2016;124(4):1018-24. PMID26473783.

Lester-Coll NH, Dosoretz AP, Hayman JA, Yu JB. Health State Utilities for Patients with Brain Metastases. Cureus. 2016;8(7):e667. PMID27551647

Kole AJ, Park HS, Yeboa DN, Rutter CE, Corso CD, Aneja S, Lester-Coll NH, Mancini BR, Knisely JP, Yu JB. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme. Cancer. 2016;122(15):2364-70. PMID27172136.

Lester-Coll NH, Dosoretz AP, Magnuson WJ, Laurans MS, Chiang VL, Yu JB. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases. J Neurosurg. 2016;125(Suppl 1):18-25. PMID27903191.

Yeboa DN, Rutter CE, Park HS, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Contessa J, Yu JB. Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas. Radiother Oncol. 2017; 125(2):258-265; PMID29054377

Kann BH, Park HS, Johnson SB, Chiang VL, Yu JB. Radiosurgery for Brain Metastases: Changing Practice Patterns and Disparities in the United States. J Natl Compr Canc Netw. 2017;15(12):1494-1502. PMID29223987.


Arnold BN, Chiu AS, Hoag JR, Kim CH, Salazar MC, Blasberg JD, Boffa DJ. Spontaneous regionalization of esophageal cancer surgery: an analysis of the National Cancer Database. J Thorac Dis. 2018;10(3):1721-1731. PMID29707326.


Kardos SV, Gross CP, Shah ND, Schulam PG, Trinh QD, Smaldone MC, Sun M, Weight CJ, Sammon J, Han LC, Kim SP. Association of type of renal surgery and access to robotic technology for kidney cancer: results from a population-based cohort. BJU Int. 2014;114(4):549-54. PMID24571281.

Kim SP, Gross CP, Meropol N, Kutikov A, Smaldone MC, Shah ND, Yu JB, Psutka S, Kiechle J, Abouassaly R. National treatment trends among older patients with T1-localized renal cell carcinoma. Urol Oncol. 2017;35(3):113.e15-113.e21. PMID27839926.


Gupta A, Long JB, Chen J, Gross CP, Feldman DR, Steingart RM. Risk of Vascular Toxicity with Platinum Based Chemotherapy in Elderly Patients with Bladder Cancer. J Urol. 2016;195(1):33-40. PMID26341576.

Wang EH, Yu JB. Chemoradiation Therapy for Organ Preservation in Localized Male Urethral Carcinoma. Oncology (Williston Park). 2016;30(6):520-3. PMID27306708.


Yang DX, Soulos PR, Davis B, Gross CP, Yu JB. Impact of widespread cervical cancer screening: number of cancers prevented and changes in race-specific incidence. Am J Clin Oncol. 2018; 41(3):289-294. PMID26808257.


Aneja SGross CPSoulos PRYu JB. Geographical Information Systems: Applications and limitations in oncology research. Oncology. 2011;25(12):1221-5. PMID22229219.

Aneja S, Smith BD, Gross CPWilson LD, Haffty BG, Roberts KBYu JB. A geographic analysis of the radiation oncology workforce. Int J Radiat Oncol Biol Phys. 2012;82(5):1723-9. PMID21493013.

Ross JS, Lehman R, Gross CP. The importance of clinical trial data sharing: toward more open science. Circ Cardiovasc Qual Outcomes. 2012;5(2):238-40. PMID22438465.

Park HSMakarov DGross CPYu B. Immortal time bias: A frequently unrecognized threat to validity in the evaluation of postoperative radiation therapy. Int J Radiat Oncol Biol Phys. 2012;83(5):1365-73 PMID22342097.

Lloyd S, Buscariollo DL, Gross CP, Makarov DV, Yu JB. Determinants of enrollment in cancer clinical trials: the relationship between the current state of knowledge, societal disease burden, and randomized clinical trial enrollment. J Natl Compr Canc Netw. 2013;11(8):928-36. PMID23946172.

Fox JP, Jeffery DD, Williams TV, Gross CP. Quality of cancer survivorship care in the military health system (TRICARE). Cancer J. 2013;19(1):1-9. PMID23337750

Yu JB. Introducing a New Resource for Readers of ONCOLOGY: The American College of Radiology Appropriateness Criteria. Oncology. 2013;27(8). PMID25184482

Aneja S, Wilson LD, Haffty BG, Yu JB. National residency matching program results for radiation oncology: 2012 update. Int J Radiat Oncol Biol Phys. 2013;86(3):402-4. PMID23708083

Jairam V, Roberts KB, Yu JB. Historical trends in the use of radiation therapy for pediatric cancers: 1973-2008. Int J Radiat Oncol Biol Phys. 2013;85(3):e151-5. PMID23273995

Vashi AA, Fox JP, Carr BG, D'Onofrio G, Pines JM, Ross JS, Gross CP. Use of hospital-based acute care among patients recently discharged from the hospital. JAMA. 2013;309(4):364-71. PMID23340638.

Aneja S, Yu JB. Comparative effectiveness research in radiation oncology: stereotactic radiosurgery, hypofractionation, and brachytherapy. Semin Radiat Oncol. 2014;24(1):35-42. PMID24314340.

Gross CP. Cancer screening in older persons: A new age of wonder. JAMA Intern Med. 2014;174(10):1565-7. PMID25133660

Maroongroge S, Dosoretz AP, Kim SP, Gross CP, Yu JB. Revisiting the sustainable growth rate "hole": sources of healthcare cost stabilization in 2010-2012. Int J Radiat Oncol Biol Phys. 2014;90(5):983-5. PMID25539361.

Batouli A, Jahanshahi P, Gross CP, Makarov DV, Yu JB. The global cancer divide: relationships between national healthcare resources and cancer outcomes in high-income vs. middle- and low-income countries. J Epidemiol Glob Health. 2014;4(2):115-24. PMID24857179.

Fox JP, Vashi AA, Ross JS, Gross CP. Hospital-based, acute care after ambulatory surgery center discharge. Surgery. 2014;155(5):743-53. PMID24787100.

Jagsi R, Bekelman JE, Chen A, Chen RC, Hoffman K, Shih YC, Smith BD, Yu JB. Considerations for observational research using large data sets in radiation oncology. Int J Radiat Oncol Biol Phys. 2014;90(1):11-24. PMID25195986

Gross CP, Fried TR, Tinetti ME, Ross JS, Genao I, Hossain S, Wolf E, Lewis CL. Decision-making and cancer screening: A qualitative study of older adults with multiple chronic conditions. J Geriatr Oncol. 2015;6(2):93-100. PMID25544380.

Maroongroge S, Kim SP, Mougalian S, Johung K, Decker RH, Soulos PR, Long JB, Gross CP, Yu JB. The Cost of Cancer-Related Physician Services to Medicare. Yale J Biol Med. 2015;88(2):107-14. PMID26029009

Bui DL, Yu JB. Trends in Adjuvant and Neoadjuvant Radiotherapy for Cancer Treatment From 1973 to 2011. Cancer J. 2015;21(3):147-9. PMID26049692

Campbell AM, Glover J, Chiang VL, Gerrard J, Yu JB. Gamma knife stereotactic radiosurgical thalamotomy for intractable tremor: a systematic review of the literature. Radiother Oncol. 2015;114(3):296-301. PMID25690750

Rutter CE, Yu JB, Wilson LD, Park HS. Assessment of national practice for palliative radiation therapy for bone metastases suggests marked underutilization of single-fraction regimens in the United States. Int J Radiat Oncol Biol Phys. 2015;91(3):548-55. PMID25542310.

Wang SY, Aldridge MD, Gross CP, Canavan M, Cherlin E, Johnson-Hurzeler R, Bradley E. Geographic Variation of Hospice Use Patterns at the End of Life. J Palliat Med. 2015;18(9):771-80. PMID26172615

Yu JB, Soulos PR, Gross CP. The Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at Yale: A Partnership of Researchers and Clinicians to Enhance Clinical Discovery. Contemporary Radiation Oncology. 2015;1(2):32-33.

Howard DH, Gross CP. Producing Evidence to Reduce Low-Value Care. JAMA Intern Med. 2015;175(12):1893-4. PMID26457957

Gross CP, Emanuel EJ. A Call for Value in Cancer Research. JAMA Oncol. 2016;2(1):11-2. PMID26447464

Jairam V, Yu JB. Examination of Industry Payments to Radiation Oncologists in 2014 Using the Centers for Medicare and Medicaid Services Open Payments Database. Int J Radiat Oncol Biol Phys. 2016;94(1):19-26. PMID26547386.

Wang SY, Aldridge MD, Gross CP, Canavan M, Cherlin E, Johnson-Hurzeler R, Bradley E. Transitions Between Healthcare Settings of Hospice Enrollees at the End of Life. J Am Geriatr Soc. 2016;64(2):314-22. PMID26889841

Wang SY, Hall J, Pollack CE, Adelson K, Bradley EH, Long JB, Gross CP. Trends in end-of-life cancer care in the Medicare program. J Geriatr Oncol. 2016;7(2):116-25. PMID26783015

Neugut AI, Gross CP. Targeting the Cancer Moonshot. JAMA Oncol. 2016;2(4):421-2 . PMID26940477.

Wang SY, Aldridge MD, Gross CP, Canavan M, Cherlin E, Johnson-Hurzeler R, Bradley E. End-of-Life Care Intensity and Hospice Use: A Regional-level Analysis. Med Care. 2016;54(7):672-8. PMID27111747

Huntington SF, Gross CP. Negative Studies in Cancer Research: Why the Negativity? JAMA Oncol. 2016;2(7):865-6. PMID26967116.

Wang SY, Hsu SH, Gross CP, Sanft T, Davidoff AJ, Ma X, Yu JB. Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis. Value Health. 2016;19(5):631-8. PMID27565280

Wang SY, Hall J, Pollack CE, Adelson K, Davidoff AJ, Long JB, Gross CP. Associations Between End-of-Life Cancer Care Patterns and Medicare Expenditures. J Natl Compr Canc Netw. 2016;14(8):1001-8. PMID27496116.

Wang SY, Aldridge MD, Canavan M, Cherlin E, Bradley E. Continuous home care reduces hospice disenrollment and hospitalization after hospice enrollment. J Pain Symptom Manage. 2016;52(6):813-821. PMID27697564

Huntington SF, Davidoff AJ. High-Cost, High-Value Oral Specialty Drugs: More Evidence on the Impact of Cost Sharing in Medicare Part D. J Clin Oncol. 2016;34(36):4307-4309. PMID27998230.

Encinosa W, Davidoff AJ. Changes in Antiemetic Overuse in Response to Choosing Wisely Recommendations. JAMA Oncol. 2017;3(3):320-326. PMID27632203

Wang S, Hsu SH, Huang S, Soulos PR, Gross CP. Longer Periods Of Hospice Service Associated With Lower End-Of-Life Spending In Regions With High Expenditures. Health Aff. 2017;36(2):328-336. PMID28167723.

Wang SY, Dang W, Aldridge MD, Canavan M, Cherlin E, Bradley E. Associations of Hospice Disenrollment and Hospitalization With Continuous Home Care Provision. Med Care. 2017;55(9):848-855. PMID28692573

Chen WS, Townsend JP, Yu JB. Radiation-Specific Clinical Data Should Be Included in Existing Large-Scale Genomic Datasets. Int J Radiat Oncol Biol Phys. 2017;98(1):8-10. PMID28587055

Wang SY, Aldridge MD, Gross CP, Canavan M, Cherlin E, Bradley E. End-of-Life Care Transition Patterns of Medicare Beneficiaries. J Am Geriatr Soc. 2017;65(7):1406-1413. PMID28369785.

Zeidan AM, Gore SD, Davidoff AJ. US Food and Drug Administration Black Box Warning and Its Impact on the Use of Erythropoiesis-Stimulating Agents: Thinking Outside the Box. J Clin Oncol. 2017;35(28):3264. PMID28787256.

Johnson SB, Park HS, Gross CP, Yu JB. Use of Alternative Medicine for Cancer and Its Impact on Survival. J Natl Cancer Inst. 2018; 110(1). PMID28922780

Davidoff AJ, Guy GP Jr, Hu X, Gonzales F, Han X, Zheng Z, Parsons H, Ekwueme DU, Jemal A. Changes in Health Insurance Coverage Associated With the Affordable Care Act Among Adults With and Without a Cancer History: Population-based National Estimates. Med Care. 2018; 56(3):220-227. PMID29438192

Maroongroge S, Yu JB. Medicare Cancer Screening in the Context of Clinical Guidelines: 2000 to 2012. Am J Clin Oncol. 2018;41(4):339-347. PMID26886947.